ROS Acquisition Offshore LP Attn: Neil Gray C/O Walkers Corporate Services Limited Walker House, 87 Mary Street George Town, Grand Cayman KY 1-9005 Cayman Islands OrbiMed Advisors LLC Attn: Matthew RizzoLetter Agreement • October 24th, 2016 • Unilife Corp • Surgical & medical instruments & apparatus • New York
AMENDMENT TO LETTER AGREEMENTLetter Agreement • October 24th, 2016 • Unilife Corp • Surgical & medical instruments & apparatus
THIS AMENDMENT (this “Amendment”), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (“Unilife”), and MICHAEL C. RATIGAN (“Ratigan”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 24th, 2016 • Unilife Corp • Surgical & medical instruments & apparatus • Pennsylvania
THIS EMPLOYMENT AGREEMENT is made and entered into as of this 5th day of November 2015, by and between Unilife Corporation ("Unilife") and Stephanie T. Walters ('Walters"). The term "Unilife" shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7, 8, and 13.
EMPLOYMENT AGREEMENTEmployment Agreement • October 24th, 2016 • Unilife Corp • Surgical & medical instruments & apparatus • Pennsylvania
THIS EMPLOYMENT AGREEMENT is made and entered into on this 21st day of October 2016, by and between Unilife Corporation ("Unilife") and Ian Hanson ("Hanson"). The term “Unilife” shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7 and 13.
Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Attention: Corporate Secretary (Fax: (805) 447-1010) Re:Waiver of Rights Under SPA and Promissory Note Ladies and Gentlemen:Unilife Corp • October 24th, 2016 • Surgical & medical instruments & apparatus
Reference is made herein to that certain (i) Securities Purchase Agreement (the “SPA”), dated as of February 22, 2016, by and among Unilife Corporation (“Unilife”), Unilife Medical Solutions, Inc. (“UMS”) and Amgen Inc. (“Amgen”); and (ii) 6% Senior Secured Convertible Note Due 2023, dated as of February 22, 2016, issued by Unilife and UMS to Amgen in the aggregate principal amount of U.S. $30,0000,000 (the “2016 Note”). Capitalized terms used herein but otherwise not defined shall have the meanings ascribed to such terms in the SPA.
